Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-κB pathway.
about
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinomaDistinct Biochemical Pools of Golgi Phosphoprotein 3 in the Human Breast Cancer Cell Lines MCF7 and MDA-MB-231The multiple cellular functions of the oncoprotein Golgi phosphoprotein 3Increased Expression of GOLPH3 is Associated with the Proliferation of Prostate Cancer.Golgi phosphoprotein 3 regulates metastasis of prostate cancer via matrix metalloproteinase 9.Short interfering RNA directed against the GOLPH3 gene enhances the effect of chemotherapy against oral squamous cell carcinoma by regulating Caspase3, Bcl2 and cytochrome-c expression.Regulation of CD44 expression and focal adhesion by Golgi phosphatidylinositol 4-phosphate in breast cancer.Psoralidin inhibits proliferation and enhances apoptosis of human esophageal carcinoma cells via NF-κB and PI3K/Akt signaling pathways.miR-186 inhibits cell proliferation of prostate cancer by targeting GOLPH3Identification of prostate cancer biomarkers in urinary exosomes.Golgi phosphoprotein3 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis.Voltage-gated sodium channel Nav 1.7 promotes gastric cancer progression through MACC1-mediated upregulation of NHE1.The ubiquitin ligase Cullin5SOCS2 regulates NDR1/STK38 stability and NF-κB transactivation.The Emerging Role of Non-traditional Ubiquitination in Oncogenic Pathways.Golgi-Related Proteins GOLPH2 (GP73/GOLM1) and GOLPH3 (GOPP1/MIDAS) in Cutaneous Melanoma: Patterns of Expression and Prognostic Significance.Correlation of GOLPH3 Gene with Wnt Signaling Pathway in Human Colon Cancer Cells.The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway.GOLPH3 and YB-1 Are Novel Markers Correlating With Poor Prognosis in Prostate Cancer.GOLPH3: a novel biomarker that correlates with poor survival and resistance to chemotherapy in breast cancer.Golgi phosphoprotein 3 promotes glioma progression via inhibiting Rab5-mediated endocytosis and degradation of epidermal growth factor receptor.Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway.
P2860
Q26784412-431B4C39-6048-4338-AD56-4E1795A524A4Q27348648-A6816C55-8953-4BEF-A5B7-1442F28439B9Q28082896-3D053E8E-9309-43F8-A914-80DD43BEEF7FQ35349161-63B38DF9-FA36-48EF-86A8-F7A90FF6C132Q35740972-2E37C435-8AF9-4339-860D-2105861D2530Q36182895-CA4F19FB-2A1A-499B-BF4F-F3FEF2B4F1E8Q37098317-84D84091-786A-448B-B98C-70F3510D916AQ37107878-9CEC35F4-ABDF-4CA0-A986-0A6492218BAEQ37215525-B342F0FB-7E83-4F0C-94E4-F13B54DA5F3AQ38286457-87C0DCD0-77E7-4786-BCD5-E50A9C3DBAD5Q38652829-2BC599BC-0DA1-47CC-928F-D266920A882AQ38751561-2A0669FD-D8B7-43B5-9A05-7FA7520BAE9CQ38952677-51CF0165-5636-41CB-BA47-73267E259101Q39116600-99202553-6E8F-4D76-AC71-AB688FFB23D4Q40553485-AE4489D2-3C72-4A3E-8631-7147DE7F2453Q41828002-1B3339E4-D36F-4BF0-A284-D8380E841901Q42278865-90ACA92A-F173-40B3-8A50-A90E88ABC602Q42286687-2806DC52-E79F-4F98-80F4-67DC9616F536Q47161478-5606798C-11CB-48BD-99A4-5217ADD439C9Q52092746-1E92B220-530C-4D07-A8E7-F447F3DE3C2DQ55383326-41491C6D-87C1-4946-9B5F-E56E497D3CB1
P2860
Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-κB pathway.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Golgi phosphoprotein 3 (GOLPH3 ...... activating the NF-κB pathway.
@en
type
label
Golgi phosphoprotein 3 (GOLPH3 ...... activating the NF-κB pathway.
@en
prefLabel
Golgi phosphoprotein 3 (GOLPH3 ...... activating the NF-κB pathway.
@en
P2093
P2860
P356
P1476
Golgi phosphoprotein 3 (GOLPH3 ...... activating the NF-κB pathway.
@en
P2093
Chanjuan Wang
Dongsheng Zhang
Jueheng Wu
Libing Song
Mengfeng Li
P2860
P304
P356
10.1002/PATH.4479
P577
2015-02-01T00:00:00Z